Identification of Potential Prognostic Markers for Vulvar Cancer Using Immunohistochemical Staining of Tissue Microarrays
Authors:
- Guus FonsGFGuus Fons
- Matthe P. BurgerMBMatthe P. Burger
- Fiebo J. Ten KateFKFiebo J. Ten Kate
- Jacobus van der VeldenJVJacobus van der Velden
- 1 April 2007
- journal article
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 26 (2) , 188-193
Abstract
The aim of this study is to determine immunohistochemical markers with prognostic significance for disease-specific survival in patients with squamous cell cancer of the vulva. The study material consisted of slides and paraffin blocks of 50 vulvectomy specimens. A tissue microarray was constructed and stained with 16 antibodies. The impact of lymph node metastases, size of tumor, vascular space involvement, and the marker expression on disease-specific survival was calculated. In univariate analysis lymph node metastases, tumor size more than 4 cm, vascular space involvement, strong cyclooxygenase 2 expression, and absent Caspase 3 expression were significantly associated with disease-specific survival. In a multivariate analysis, poor disease-specific survival is independently associated with absent Caspase 3 expression (hazard ratio, 0.2; 95% confidence interval, 0.04-0.97; P = 0.045). Five-year survival was 86% in patients with tumors positive for Caspase 3 (n = 20) and drops to 64% in patients with Caspase 3-negative tumors (n = 30). In this test set, cyclooxygenase 2 and Caspase 3 seem to be immunohistochemical markers with prognostic significance for vulva cancer. The results have to be validated.Keywords
This publication has 16 references indexed in Scilit:
- Validation of tissue array technology in head and neck squamous cell carcinomaHead & Neck, 2003
- Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarraysHistopathology, 2002
- Microarrays of bladder cancer tissue are highly representative of proliferation index and histological gradeThe Journal of Pathology, 2001
- Validation of Tissue Microarrays for Immunohistochemical Profiling of Cancer Specimens Using the Example of Human Fibroblastic TumorsThe American Journal of Pathology, 2001
- Validation of Tissue Microarray Technology in Breast CarcinomaLaboratory Investigation, 2000
- Patterns of recurrence in patients with squamous cell carcinoma of the vulvaCancer, 2000
- Recurrent squamous cell carcinoma of the vulvaCancer, 2000
- Comparison of different scoring systems for immunohistochemical staining.Journal of Clinical Pathology, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (A Gynecologic Oncology Group Study)American Journal of Obstetrics and Gynecology, 1991